National Repository of Grey Literature 2 records found  Search took 0.00 seconds. 
Interaction of PPARG gene polymorphisms with diet components in pathogenesis of type 2 diabetes
Petrů, Karolína ; Šeda, Ondřej (advisor) ; Schierová, Michaela (referee)
Type 2 diabetes is a multifactorial trait as interactions between genetic predispositions and environmental factors contribute to its pathogenesis. Nuclear receptor PPARG (peroxisome proliferator-activated receptor gamma) belongs among genes with substantial impact on pathophysiological processes leading to manifestation of type 2 diabetes. Metaanalyses of human studies showed that several common polymorphisms of this gene are involved in interactions with environmental factors, particularly diet, physical activity and medication. The aim of this Bachelor thesis is to summarize current knowledge on nutrigenetic interactions comprising polymorphisms of PPARG gene and specific qualitative and quantitative parameters of the diet in relation to pathogenesis of type 2 diabetes.
Pharmacogenetics of statins and metabolic syndrome
Kučera, Miroslav ; Šeda, Ondřej (advisor) ; Schierová, Michaela (referee)
Metabolic syndrome is one of the most prevalent conditions in our population. Among components of the syndrome is a major risk factor of cardiovascular diseases - a change in blood lipid profile presented by alterations in cholesterol and triacylglycerol levels. Statins are currently the drug of choice for therapy of dyslipidemia. This group of drugs is characterized by inhibition of cholesterol synthesis in liver. Pharmacogenetics is a progressive field studying interactions between drugs and genetic background of a patient. There has been described a large amount of genetic variants affecting pharmacokinetic and pharmacodynamic aspects of statin effects. These variants were shown to be important for course of treatment and development of side effects such as statin myopathy. First, this work characterizes pharmacogenetics, metabolic syndrome and statins. Second, it provides a comprehensive summary of genetic polymorphisms underlying important pharmacogenetic interactions with statins.

Interested in being notified about new results for this query?
Subscribe to the RSS feed.